Bayard L. Powell, MD

home / authors / bayard-l-powell-md

Articles

CPI-613 in Combination With High Dose ARA-C and Mitoxantrone

CPI-613 in Combination With High Dose ARA-C and Mitoxantrone

January 6th 2015

Bayard L. Powell, MD, discusses a phase I study that looked at CPI-613 in combination with high dose ARA-C and mitoxantrone for the treatment of patents with relapsed/refractory acute myeloid leukemia (AML).